Field Trip Health (FTRPF) Stock Price, News & Analysis

Company Overview

Field Trip Health is a global mental wellness company focused on the development and delivery of psychedelic-assisted therapies and novel psychotropic compounds. Headquartered in Toronto, Canada, the company operates a network of clinics and retreat centers designed to administer ketamine-assisted treatments under the supervision of licensed mental health professionals. Field Trip Health’s services combine clinical assessments, personalized therapy protocols and integration support to address conditions such as depression, anxiety and post-traumatic stress disorder.

In its clinical segment, Field Trip Health maintains facilities across North America and Europe, including locations in Toronto, New York, Los Angeles, London and Amsterdam. The company also offers immersive retreat experiences in Jamaica, where participants undergo guided therapeutic sessions in a residential setting. Through telemedicine channels, Field Trip extends its care model to patients who require remote consultations and ongoing integration support.

Beyond its treatment centers, Field Trip Health operates a research and development arm, Field Trip Ventures, which focuses on the discovery, preclinical testing and manufacturing of next-generation psychedelic compounds. The company’s proprietary library includes molecules such as FT-104 and FT-203, which are being evaluated for safety, efficacy and optimized therapeutic profiles. Field Trip’s integrated approach—from molecule design and manufacturing to clinical delivery—aims to advance the broader adoption of psychedelic-informed mental health care.

Founded in 2019 and led by CEO Ronan Levy, Field Trip Health went public on the OTC markets under the ticker FTRPF in early 2021. Since its inception, the company has pursued strategic partnerships with research institutions, expanded its clinical footprint and built a multidisciplinary team of psychiatrists, therapists and scientists. Field Trip continues to invest in evidence-based protocols and scalable care models that seek to redefine mental health treatment paradigms.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 64,700 shs
• Average Volume: 59,938 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

FTRPF Stock Analysis - Frequently Asked Questions

How do I buy shares of Field Trip Health?

Shares of FTRPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Care Facilities
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:FTRPF
• CIK: N/A
• Web: www.fieldtriphealth.com
• Phone: 833 222 0084
• Fax: N/A
• Employees: 104
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A